The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenew Holdings Regulatory News (RNWH)

Share Price Information for Renew Holdings (RNWH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 937.00
Bid: 935.00
Ask: 938.00
Change: -1.00 (-0.11%)
Spread: 3.00 (0.321%)
Open: 928.00
High: 943.00
Low: 928.00
Prev. Close: 938.00
RNWH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

21 Dec 2022 07:00

RNS Number : 3644K
Renew Holdings PLC
21 December 2022
 

21 December 2022

 

Renew Holdings plc

 

("Renew" or the "Group")

 

Director/PDMR Shareholding

 

 

Renew (AIM: RNWH), the leading Engineering Services Group supporting the maintenance and renewal of critical UK infrastructure, announces that a total of 232,092 options ("LTIP Options") have been granted on 20 December 2022 to subscribe for ordinary shares of 10p each pursuant to the Company's Long Term Incentive Plan adopted on 25 January 2012 as amended by certain rule changes approved at the Annual General Meeting held on 27 January 2016. The grant includes the following allocation to executive directors of Renew:

 

P Scott (Chief Executive)

83,696

A Liebenberg (Executive Director)

60,870

S Wyndham-Quin (Chief Financial Officer)

64,130

 

The LTIP Options are exercisable at an exercise price of 10p per ordinary share from 21 December 2025 but are only exercisable to the extent that certain performance criteria are achieved by the Company over a three-year performance period commencing 1 October 2022. The LTIP Options must be exercised before 21 December 2032.

 

A summary of the performance criteria is set out in the Directors' Remuneration Report in the Annual Report and Accounts which is available on the Company's website and from the registered office.

 

The total number of ordinary shares of 10p each in issue is 78,862,743 and following the above LTIP award there is a total of 941,173 outstanding none of which have yet vested. 

 

For further information, please contact:

 

Renew Holdings plc

www.renewholdings.com

 

Paul Scott, Chief Executive Officer

Sean Wyndham-Quin, Chief Financial Officer

 

via FTI Consulting

020 3727 1000

Numis Securities Limited (Nominated Adviser & Joint Broker)

Stuart Skinner/ Kevin Cruickshank

 

Peel Hunt LLP (Joint Broker)

Mike Burke / Harry Nicholas / Charles Batten

 

020 7260 1000

 

 

 

020 7418 8900

FTI Consulting (Financial PR)

Alex Beagley / Sam Macpherson / Rafaella de Freitas

020 3727 1000

Renew@fticonsulting.com

About Renew Holdings plc

Renew is a leading UK Engineering Services business, performing a critical role in keeping the nation's infrastructure functioning efficiently and safely. The Group operates through independently branded subsidiaries across its chosen markets, delivering non-discretionary maintenance and renewal tasks through its highly skilled, directly employed workforce.

 

Renew's activities are focused into two business streams: Engineering Services, which accounts for over 95 per cent of the Group's adjusted operating profit, focuses on the key markets of Rail, Infrastructure, Energy (including Nuclear) and Environmental which are largely governed by regulation and benefit from non-discretionary spend with long-term visibility of committed funding.

 

Specialist Building focuses on the High Quality Residential, Landmark and Science markets in London and the Home Counties.

 

For more information please visit the Renew Holdings plc website: www.renewholdings.com  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFISFTLIFIF
Date   Source Headline
9th Apr 20247:00 amRNSAcquisition of Route One
2nd Apr 20247:00 amRNSH1 Update, Directorate Change & Notice of Results
28th Feb 20247:59 amRNSHolding(s) in Company
30th Jan 202411:39 amRNSResult of AGM
30th Jan 20247:00 amRNSAGM Statement
21st Dec 202310:29 amRNSHolding(s) in Company
21st Dec 20237:00 amRNSAnnual Report & Accounts and Notice of AGM
20th Dec 202311:47 amRNSIssue of Equity
19th Dec 20235:12 pmRNSExercise of Options
8th Dec 20231:38 pmRNSDirector/PDMR Shareholding
28th Nov 20237:00 amRNSFinal Results
7th Nov 202311:00 amRNSNotice of Results
27th Oct 20237:00 amRNSAcquisition of TIS
2nd Oct 20237:00 amRNSYear End Trading Update
25th Sep 20233:33 pmRNSHolding(s) in Company
4th Sep 20233:57 pmRNSHolding(s) in Company
15th Aug 202310:00 amRNSHolding(s) in Company
15th Jun 20233:16 pmRNSHolding(s) in Company
16th May 20237:00 amRNSHalf-year Report
3rd Apr 20237:00 amRNSH1 Trading Update & Notice of Results
21st Mar 202312:07 pmRNSDirector/PDMR Shareholding
10th Mar 20237:00 amRNSIssue of Equity & Director Dealing
1st Feb 202312:20 pmRNSResult of AGM
1st Feb 20237:00 amRNSAGM Statement
10th Jan 20231:39 pmRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector/PDMR Shareholding
22nd Dec 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
21st Dec 20227:00 amRNSDirector/PDMR Shareholding
8th Dec 202212:16 pmRNSDirector/PDMR Shareholding
29th Nov 20227:00 amRNSAcquisition of Enisca
29th Nov 20227:00 amRNSFinal Results
10th Nov 20227:00 amRNSNotice of Results
1st Nov 20227:00 amRNSAppointment of Non-Executive Director
3rd Oct 20227:00 amRNSYear End Trading Update
29th Sep 20224:24 pmRNSDirector/PDMR Shareholding
21st Sep 202212:40 pmRNSDirector/PDMR Shareholding
13th Sep 20224:19 pmRNSDirector / PDMR Shareholding
15th Aug 20227:00 amRNSAppointment of Non-Executive Director
17th May 20227:00 amRNSDirectorate Change
17th May 20227:00 amRNSHalf-year Report
1st Apr 20227:00 amRNSH1 Trading Update
10th Mar 20227:00 amRNSDirectorate Change
26th Jan 202212:02 pmRNSResult of AGM
26th Jan 20227:00 amRNSAGM Statement
19th Jan 20225:09 pmRNSDirector/PDMR Shareholding
21st Dec 20217:00 amRNSAnnual Report & Accounts and Notice of AGM
16th Dec 20217:00 amRNSIssue of Equity & Director Dealing
9th Dec 20217:00 amRNSDirectorate Change
9th Dec 20217:00 amRNSFinal Results
6th Dec 20215:01 pmRNSFinal Results Revised Date

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.